DiseasesChronic inflammation — the quiet fire that fuels disease?
- Paul Clayton — Dlaczego boli nas coraz dokuczliwiej?
- Paul Clayton — Wspomnienie Lorda Vadera, czyli o związku flory jelitowej z bezdechem nocnym
- Paul Clayton — Twoje oszukane serce
- Paul Clayton — Współdziałanie flory jelitowej z mózgiem
- Hubert Czerniak — Reumatoidalne zapalenie stawów - poznaj prawdę o tej chorobie
- Henryk Różański — Choroba Hashimoto, czyli przewlekłe autoimmunologiczne zapalenie tarczycy, część 1.
- Piotr Witczak — Metformina kontra berberyna w leczeniu chorób metabolicznych
- M. Williamson i N. Moustaid-Moussa i L. Gollahon — Frontiers | The Molecular Effects of Dietary Acid Load on Metabolic Disease (The Cellular PasaDoble: The Fast-Paced Dance of pH Regulation)
- Andrzej Frydrychowski — Artroza i co dalej?
- Low-Grade Chronic Inflammation: a Shared Mechanism for Chronic Diseases. · Physiology (Bethesda) 2025
- Chronic Inflammation as an Immunological Abnormality and Effectiveness of Exercise. · Biomolecules 2019
- Inflammation, ageing and chronic disease. · Curr Opin Immunol 2014
- Role of Antioxidants and Natural Products in Inflammation. · Oxid Med Cell Longev 2016
- The potential of food protein-derived anti-inflammatory peptides against various chronic inflammatory diseases. · J Sci Food Agric 2016
- Chronic inflammation and mutagenesis. · Mutat Res 2010
- Inflammation and cachexia in chronic kidney disease. · Pediatr Nephrol 2010
- Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. · Arch Gynecol Obstet 2021
- Inflammation-Mediated Causal Effects of MRI-Defined Body-Composition Obesity Axes on Chronic Obstructive Pulmonary Disease, Asthma, and Allergic Rhinitis: A Mendelian Randomization Study. · Int J Chron Obstruct Pulmon Dis 2026
- Regulatory T cells exhibit differential therapeutic effects across tissues during chronic autoimmune inflammation. · Int Immunol 2026
- Orthomolecular Medicine News Service — Schizophrenia Is Chronic Encephalitis... and Niacin Cures It
- Orthomolecular Medicine News Service — The Vital Role of NAD+ and Niacin in Longevity and Well-being
- Orthomolecular Medicine News Service — A Holistic Approach to ASCVD:Summary of a Novel Framework and Report of 10 Case Studies
Paul Clayton points out that a pro-inflammatory diet may increase the risk of acute pain becoming chronic.
- Mild, short-term inflammation supports immunity, memory, and injury healing, while excessive or chronic inflammation can lead to depression and neurodegenerative diseases.
- Clayton also links chronic inflammation with atrial fibrillation and sleep apnea.
- Hubert Czerniak describes rheumatoid arthritis (RA) as a disease in which antibodies against cartilage trigger inflammation, pain, and joint swelling.
What the authors write
Mild, temporary inflammation supports immune surveillance, brain development, memory, and injury healing; excessive or chronic inflammation can lead to sickness behavior, depression, and neurodegenerative diseases.
Paul Clayton points out that a pro-inflammatory diet may increase the risk of acute pain becoming chronic, and that dysbiosis may play a part.
Paul Clayton links more frequent consumption of ultra-processed, pro-inflammatory foods with an increase in reports of chronic pain.
Paul Clayton describes sleep apnea as a disorder in which inflammation plays a significant part and suggests that chronic inflammatory stress may precede it.
Paul Clayton identifies chronic inflammation as an important part of the progression of atrial fibrillation.
Paul Clayton links chronic inflammatory stress with the development of atrial fibrillation, and higher inflammatory biomarkers with a greater risk of the disease.
Paul Clayton describes neuroinflammation as an important cause of epilepsy and links it with oxidative stress.
Hubert Czerniak describes RA as a disease in which antibodies against cartilage trigger inflammation, pain, swelling, and impaired joint function.
Henryk Różański describes Hashimoto’s disease as thyroid inflammation associated with antibodies against the thyroid’s own components, which can lead to hypothyroidism.
Henryk Różański describes lymphocyte attacks on thyroid cells as a cause of their damage or destruction.
Piotr Witczak points out that obesity is accompanied by low-grade chronic inflammation and that limiting it may slow disease progression.
M. Williamson, N. Moustaid-Moussa, and L. Gollahon list inflammation as a feature of metabolic diseases and cancer.
Hubert Czerniak identifies dysbiosis as an early causal factor in the inflammatory process in the joints that he describes.
Andrzej Frydrychowski recommends limiting foods that he says increase inflammation, as well as regular exercise when joints are undernourished.
Paul Clayton warns that in the study he describes, drug-based suppression of neutrophils after an injury was linked with a greater risk of chronic pain.
Research from PubMed · Europe PMC
We selected 10 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 139 972.
The review indicates that low-grade chronic inflammation is strongly associated with the development of obesity, cancer, and cardiovascular disease.
Aim of the study: Inflammation is an important physiological response of the organism to restore homeostasis upon pathogenic or damaging stimuli. However, the persistence of the harmful trigger or a deficient resolution of the process can evolve into a state of low-grade, chronic inflammation.
Results: This condition is strongly associated with the development of several increasingly prevalent and serious chronic conditions, such as obesity, cancer, and cardiovascular diseases, elevating overall morbidity and mortality worldwide. The current pandemic of chronic diseases underscores the need to address chronic inflammation, its pathogenic mechanisms, and potential preventive measures to limit its current widespread impact. The present review discusses the current knowledge and research gaps regarding the association between low-grade chronic inflammation and chronic diseases, focusing on obesity, cardiovascular diseases, digestive diseases, and cancer. We examine the state of the art in selected aspects of the topic and propose future directions and approaches for the field.
“Not stated” does not mean nobody paid — the database does not always record it.
The review describes how chronic inflammation can damage blood vessels and organs and is linked with many chronic diseases.
Aim of the study: Reduced levels of physical activity in people's daily lives cause the development of metabolic syndromes or age-related disorders. Chronic inflammation is now understood to be an underlying pathological condition in which inflammatory cells such as neutrophils and monocyte/macrophages infiltrate into fat and other tissues and accumulate when people become obese due to overeating and/or physical inactivity.
Results: Chronic inflammation is also involved in sarcopenia that brings hypofunction in the elderly, dementia, osteoporosis, or cancer and negatively affects many chronic diseases and people's healthy life expectancy. In this paper, outlines of such studies are introduced in terms of homeostatic inflammation, which occurs chronically due to the innate immune system and its abnormalities, while focusing on the efficacy of exercise from aspects of immunology and oxidative stress. The preventative effects of functional food ingredients in combination with exercise are also introduced and described. The challenges and future directions in understanding the role of exercise in the control of chronic inflammation are discussed.
“Not stated” does not mean nobody paid — the database does not always record it.
The review indicates that signs of chronic inflammation in older people are associated with many age-related diseases.
Aim of the study: Acute inflammatory responses are essential for pathogen control and tissue repair but can also cause severe collateral damage. Tight regulation of the response is required to minimize host injury, but in the face of chronic infections and age-associated immune dysregulation, inflammatory processes may exert multiple detrimental effects on the organism.
Results: Acute inflammatory responses are essential for pathogen control and tissue repair but can also cause severe collateral damage. Tight regulation of the response is required to minimize host injury, but in the face of chronic infections and age-associated immune dysregulation, inflammatory processes may exert multiple detrimental effects on the organism. The signs of low level systemic inflammation commonly detectable in elderly people are associated with many chronic diseases of ageing and may even contribute to their causation. The purpose of this article is to review recent literature from the past two years providing new data on the inter-relationships between inflammatory status and chronic diseases of ageing.
“Not stated” does not mean nobody paid — the database does not always record it.
The review describes inflammation as an important factor in the progression of many chronic diseases.
Aim of the study: Inflammation is a comprehensive array of physiological response to a foreign organism, including human pathogens, dust particles, and viruses. Inflammations are mainly divided into acute and chronic inflammation depending on various inflammatory processes and cellular mechanisms.
Results: Free radical productions from different biological and environmental sources are due to an imbalance of natural antioxidants which further leads to various inflammatory associated diseases. In this review article, we have outlined the inflammatory process and its cellular mechanisms involved in the progression of various chronic modern human diseases. In addition, we have discussed the role of free radicals-induced tissue damage, antioxidant defence, and molecular mechanisms in chronic inflammatory diseases/disorders. The systematic knowledge regarding the role of inflammation and its associated adverse effects can provide a clear understanding in the development of innovative therapeutic targets from natural sources that are intended for suppression of various chronic inflammations associated diseases.
“Not stated” does not mean nobody paid — the database does not always record it.
The review indicates that inflammation is considered one of the main causes of many chronic diseases.
Aim of the study: Inflammation is considered as one of the major causes for the initiation of various chronic diseases such as asthma, cancer, cardiovascular disease, diabetes, obesity, inflammatory bowel disease, osteoporosis and neurological diseases like Parkinson's disease.
Results: Increasing scientific evidence has delineated that inflammatory markers such as TNF-α, IL-1, IL-6, IL-8 and CRP and different transcription factors such as NF-κB and STAT are the major key factors that regulate these inflammatory diseases. Food protein-derived bioactive peptides have been shown to exhibit anti-inflammatory activity by inhibiting or reducing the expression of these inflammatory biomarkers and/or by modulating the activity of these transcription factors. This review aims to discuss various molecular targets and underlying mechanisms of food protein-derived anti-inflammatory peptides and to explore their potential against various chronic inflammatory diseases. © 2015 Society of Chemical Industry.
“Not stated” does not mean nobody paid — the database does not always record it.
The review describes how persistent inflammation may increase the risk of chronic diseases and contribute to mutations.
Aim of the study: Inflammation is a necessary part of the immune response. However, when inflammation persists, the resultant state of chronic inflammation may have a number of secondary consequences associated with increased risk of chronic disease.
Results: While frameshift and chromosomal mutations have been associated with chronic inflammation, much of the evidence reveals base pair substitution mutations associated with polymerase stalling near the lesions, and base pair mis-incorporation. There are also indirect effects of ROS/RNS through inhibition of DNA repair enzymes and/or effects on metabolic activation of known carcinogens. Certain disease states, including the Inflammatory bowel diseases, Crohn's disease and ulcerative colitis are associated with enhanced levels of chronic inflammation, and show evidence of enhanced levels of genetic damage in the colonic mucosa. Mutations may provide at least part of the cause of enhanced susceptibility to chronic diseases associated with chronic inflammation.
“Not stated” does not mean nobody paid — the database does not always record it.
The review links chronic inflammation in kidney disease with wasting and a higher risk of death.
Aim of the study: Chronic inflammation is associated with cachexia and increased mortality risk in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Inflammation suppresses appetite and causes the loss of protein stores.
Results: In CKD patients, increased serum levels of pro-inflammatory cytokines may be caused by reduced renal function, volume overload, oxidative or carbonyl stress, decreased levels of antioxidants, increased susceptibility to infection in uremia, and the presence of comorbid conditions. Cachexia is brought about by the synergistic combination of a dramatic decrease in appetite and an increase in the catabolism of fat and lean body mass. Pro-inflammatory cytokines act on the central nervous system to alter appetite and energy metabolism and to provide a signal-through the nuclear factor-kappaB and ATP-ubiquitin-dependent proteolytic pathways-that causes muscle wasting. Further research into the molecular pathways leading to inflammation and cachexia may lead to novel therapeutic therapies for this devastating and potentially fatal complication of chronic disease.
“Not stated” does not mean nobody paid — the database does not always record it.
The review indicates that inflammatory markers are associated with the development of polycystic ovary syndrome.
Aim of the study: Polycystic ovarian syndrome (PCOS) is the most prevalent metabolic disorder in reproductive-age women. It is indeed a multifactorial condition evidenced by ovarian dysfunction, hyperandrogenaemia, infertility, hormonal imbalance and chronic anovulation. Experimental evidence infers that PCOS women are prone to cardiovascular problems and insulin resistance. To furnish the details about the association of inflammatory markers in PCOS.
Results: The inflammatory markers perform a substantial part in managing the functions of the ovary. Any disturbances in their levels can lead to ovarian dysfunction. Inflammatory markers are associated with PCOS pathogenesis. The interplay between inflammatory cytokines in the PCOS ovary strongly implies that inflammation is one of the most potent risk factors of PCOS. Inflammatory markers have a significant role in regulating the ovary. This manuscript highlights the significance of metabolic and inflammatory markers with PCOS. Since PCOS is always considered as a metabolic disorder, researchers can also consider focusing on the relationship between the inflammatory markers in PCOS to establish a new treatment or management of the disease and to improve women's health.
“Not stated” does not mean nobody paid — the database does not always record it.
The study found that genetically predicted general obesity increased the risk of COPD, asthma, and allergic rhinitis.
Aim of the study: Obesity is heterogeneous; conventional anthropometric measures combine fat distribution, ectopic fat deposition, and muscle volume, limiting refined causal inference for chronic airway diseases. We used four magnetic resonance imaging (MRI)-defined obesity axes to assess their causal effects on chronic obstructive pulmonary disease (COPD), asthma, and allergic rhinitis (AR), and to evaluate mediation by circulating inflammatory proteins.
Results: Genetically predicted general obesity axis was associated with increased risks of COPD (OR = 1.125, 95% CI: 1.012-1.250), asthma (OR = 1.533, 95% CI: 1.426-1.647), and AR (OR = 1.624, 95% CI: 1.328-1.987). The lower-body fat axis was associated with higher risks of COPD (OR = 1.192, 95% CI: 1.088-1.306) and asthma (OR = 1.135, 95% CI: 1.052-1.224). No causal evidence was observed for the other obesity axes. Replication and meta-analysis largely supported these findings, except for general obesity and AR, which showed borderline pooled evidence (P = 0.055). Mediation analysis identified 17 candidate inflammatory pathways, of which 10 were significant. FLT3L mediated 18.17% of the effect of general obesity on COPD, and CXCL5 mediated 3.78% of its effect on asthma. CD40L receptor and LIFR mediated 5.59% and 12.65% of the lower-body fat-asthma effect, respectively, whereas CD40L receptor, CXCL10, IL-12B, OPG, and TNFRSF9 showed suppressive mediation in selected pathways.
“Not stated” does not mean nobody paid — the database does not always record it.
In mice, Treg cell therapy effectively resolved chronic skin inflammation but only slightly slowed arthritis progression.
Aim of the study: Current therapies for autoimmune diseases rely largely on non-specific immunosuppression, which can lead to adverse effects such as malignancy and severe infections. Treg-based therapies have therefore attracted attention as a more targeted approach, particularly in preventive or early-stage settings.
Results: To investigate the basis of this difference, we performed microarray and GSVA-based pathway analyses. Under untreated conditions, skin and joint tissues exhibited distinct baseline pathway activity patterns, with the skin showing higher activity of the Hippo signaling pathway, a growth-regulatory pathway, and the joints displaying stronger enrichment of inflammation-related pathways, including complement- and angiogenesis-associated pathways. Following Treg administration, skin-but not joint-tissue showed pathway modulation, including increased Wnt and decreased IL-17 signaling pathway activity, consistent with a more reparative environment. These findings indicate that distinct inflammatory environments underlie differential responsiveness to Treg therapy across tissues, highlighting their context-dependent therapeutic potential in chronic autoimmune inflammation.
“Not stated” does not mean nobody paid — the database does not always record it.
Perspectives and opinion materials
The content below presents the authors’ opinions, interpretations and hypotheses. It is not treated as equal to scientific studies and systematic reviews.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.